Medicine & Life Sciences
Parkinson Disease
100%
alpha-Synuclein
98%
HIV-1
97%
Preclinical Drug Evaluations
62%
C Chemokines
57%
Organoids
48%
CXC Chemokines
47%
CC Chemokines
47%
Mutation
45%
Tropism
44%
Carcinoid Tumor
42%
Chemokine Receptors
41%
Point Mutation
41%
Genes
40%
Cell Line
39%
Glioblastoma
36%
Dopaminergic Neurons
34%
Viruses
33%
Mitochondria
30%
Clone Cells
29%
Maraviroc
29%
Virion
28%
Induced Pluripotent Stem Cells
25%
Germ Layers
25%
Neoplasms
24%
Peptides
23%
Clustered Regularly Interspaced Short Palindromic Repeats
23%
Virus Internalization
23%
Neurons
22%
Drug Therapy
21%
Lung
19%
Mesencephalon
18%
Bacteriophages
18%
T-Lymphocytes
17%
Phenotype
17%
Neuroendocrine Tumors
16%
Pharmaceutical Preparations
16%
Pleural Effusion
15%
Genotype
15%
Therapeutics
14%
Neoplasm Metastasis
13%
Retroviridae
13%
cediranib
12%
Proteins
12%
Transgenes
12%
Parkinson Disease, Familial, Type 1
11%
Liver
11%
Investigational Drugs
10%
Macrophages
10%
Rotenone
9%
Limit of Detection
9%
Technology
9%
Capecitabine
9%
Fibroblasts
9%
Pleura
8%
Viral Genes
8%
Luciferases
8%
Viral Envelope Proteins
8%
HIV
8%
Bevacizumab
8%
Drug Discovery
7%
Karyotype
7%
Virus Replication
7%
Infections
7%
United States Food and Drug Administration
7%
Lipid Metabolism
7%
Skin
6%
Mitochondrial Diseases
6%
Libraries
6%
Humoral Immunity
6%
CD4 Lymphocyte Count
6%
Alanine
6%
Cations
6%
Neutralizing Antibodies
6%
Respiration
6%
Machine Learning
6%
Lung Neoplasms
5%
Flow Cytometry
5%
Vaccines
5%
Immunoglobulin M
5%
HIV Infections
5%
In Vitro Techniques
5%
Epitopes
5%
Antiviral Agents
5%
Ganglia
5%
Organelles
5%